Integer Holdings Corp. (ITGR)
125.31
-0.08
(-0.06%)
USD |
NYSE |
Sep 02, 16:00
125.30
0.00 (0.00%)
Pre-Market: 20:00
Integer Holdings Research and Development Expense (TTM) : 48.14M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 48.14M |
| March 31, 2026 | 51.39M |
| December 31, 2025 | 49.50M |
| September 30, 2025 | 50.00M |
| June 30, 2025 | 50.98M |
| March 31, 2025 | 52.35M |
| December 31, 2024 | 53.42M |
| September 30, 2024 | 55.86M |
| June 30, 2024 | 58.01M |
| March 31, 2024 | 59.28M |
| December 31, 2023 | 63.09M |
| September 30, 2023 | 63.88M |
| June 30, 2023 | 65.94M |
| March 31, 2023 | 63.93M |
| December 31, 2022 | 60.92M |
| September 30, 2022 | 59.81M |
| June 30, 2022 | 55.74M |
| March 31, 2022 | 54.61M |
| December 31, 2021 | 51.98M |
| September 30, 2021 | 49.84M |
| June 30, 2021 | 46.14M |
| March 31, 2021 | 45.15M |
| December 31, 2020 | 44.93M |
| September 30, 2020 | 46.15M |
| June 30, 2020 | 49.52M |
| Date | Value |
|---|---|
| March 31, 2020 | 48.18M |
| December 31, 2019 | 46.53M |
| September 30, 2019 | 44.84M |
| June 30, 2019 | 45.31M |
| March 31, 2019 | 46.81M |
| December 31, 2018 | 48.45M |
| September 30, 2018 | 51.94M |
| June 30, 2018 | 51.83M |
| March 31, 2018 | 50.04M |
| December 31, 2017 | 50.08M |
| September 30, 2017 | 48.98M |
| June 30, 2017 | 48.16M |
| March 31, 2017 | 50.55M |
| December 31, 2016 | 54.49M |
| September 30, 2016 | 54.95M |
| June 30, 2016 | 57.89M |
| March 31, 2016 | 57.36M |
| December 31, 2015 | 52.58M |
| September 30, 2015 | 49.39M |
| June 30, 2015 | 48.66M |
| March 31, 2015 | 48.29M |
| December 31, 2014 | 49.18M |
| September 30, 2014 | 43.80M |
| June 30, 2014 | 35.24M |
| March 31, 2014 | 27.54M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Globus Medical, Inc. | 147.06M |
| Integra LifeSciences Holdings Corp. | 68.59M |
| Abbott Laboratories | 3.128B |
| AngioDynamics, Inc. | 29.45M |
| Alphatec Holdings, Inc. | 76.69M |